Recent advances in proteomics have been driven by the availability of numerous annotated whole-genome sequences and a broad range of technological and bioinformatic developments that underscore the complexity of the proteome. The review by Witzmann and Grant (pp 68-75) briefly addresses some of the various technologies that comprise expression proteomics and functional proteomics, citing examples where these emerging approaches have been applied to pharmacology, toxicology, and the development of drugs.
Single nucleotide polymorphism genotyping
Many new technologies for single nucleotide polymorphism genotyping have been developed in the last few years. Rapid technological progress makes it difficult to choose appropriate methods for a given application. The article by Chen and Sullivan (pp 76-95) reviews current technologies, focusing on the underlying biochemistry, and compares and contrasts the strengths, weaknesses, throughputs, and cost structures of these technologies.
Tardive dyskinesia and the dopamine D3 receptor Tardive dyskinesia (TD) is a severe side effect of traditional neuroleptics affecting a considerable number of schizophrenic patients. Evidence suggests the existence of a genetic disposition to TD and other extra pyramidal symptoms (EPS) most strongly linked to the D3 dopamine receptor gene (DRD3). The Cebus apella monkey is the favored animal model to study TD and other EPS because of its high susceptibility to side effects of neuroleptics. The paper by Werge et al (pp 96-99) determines the sequence of the DRD3 gene in the Cebus apella monkey and compares it with that of humans.
5-HTT gene and antidepressantinduced mania
The genes involved in the serotonin system are major candidates in association studies on affective disorders and responses to antidepressants. The paper by Dellivier et al (pp 100-103) studies a functional polymorphism of the serotonin transporter (5-HTT) gene and lifetime history of antidepressant-induced mania (AIM) in a population of 305 patients with bipolar affective disorder. These results may help to explain the conflicting association results obtained with the 5-HTT gene polymorphism, in particular with AIM.
Haloperidol pharmacokinetics and pharmacodynamics
In vitro cardiac electrophysiology studies demonstrate that supratherapeutic concentrations of haloperidol prolong the heart rate corrected QT interval (QTc) by approximately 26% in an isolated perfused feline heart model. The present study by Flockhart et al (pp 104-112) determines the potential for a commonly used clinical dose of haloperidol to alter the QTc interval in healthy subjects in a prospective, randomized controlled trial. The study additionally determines the influence of CYP2D6 genotype on haloperidol disposition and QT interval pharmacodynamics.
SERMs, dominance, and 5-HT The paper by compares the effect of long-term-conjugated equine estrogen and soy phytoestrogen treatment on serotonin neurotransmission, and examines the relation between social status and serotonin neurotransmission in the dorsal raphe of cynomolgus monkeys. The protein content of tryptophan hydroxylase and serotonin reuptake transporter (SERT) was determined, and the in vitro degradation of macaque SERT protein was examined in the presence and absence of protease inhibitors, serotonin, and citalopram. 
